Taiwanese President Tsai Ing-wen is expected to stop over in the U.S. on Friday on her way back from visiting diplomatic allies in the Caribbean, a move that's sure to make...China Politicsread more
Regional stability, oil prices and potential for war will all depend on what Iran does with its nuclear program in the event of the deal's termination.World Politicsread more
Libra and bitcoin are different in a lot of ways, from the technology behind them to the way they're used.Technologyread more
Stocks in major Asia Pacific markets made strong gains on Friday, as comments from a U.S. Federal Reserve official led to rising expectations the central bank could ease...Asia Marketsread more
Boeing will take a nearly $5 billion charge in the second quarter to compensate 737 Max customers as the planes remain grounded.Airlinesread more
Earlier, Williams delivered a speech at the annual meeting of the Central Bank Research Association in which he said, "It's better to take preventative measures than to wait...The Fedread more
The base version of the sports car will punch out 495 horsepower, 40 more than the seventh-generation car and enough to launch it from 0 to 60 in "less than three seconds"...Autosread more
Animation fans and Kyoto residents gathered at the site of Japan's worst mass killing in 18 years on Friday, offering flowers and prayers for the 33 people who died in an...Asia Newsread more
Trump said the USS Boxer destroyed Iran's drone in the Strait of Hormuz on Thursday in a "defensive action."Politicsread more
Microsoft beat on top and bottom lines, and guidance was just ahead of expectations, but the company's Azure growth is slowing down.Technologyread more
"We've seen Netflix stumble before, especially maybe after a price hike, but not quite like this," Jim Cramer says.Mad Money with Jim Cramerread more
Check out which companies are making headlines before the bell:
Pharmacyclics - AbbVie is buying the cancer drug specialist for $21 billion in cash and stock. The deal is valued at about $261.25 per share, a 13 percent premium for Pharmacyclics shareholders. The stock has been rising in recent days on reports that Johnson & Johnson was on the verge of buying it.
Costco – The warehouse retailer reported quarterly profit of $1.35 per share, 17 cents above estimates. Overall revenue was slightly below estimates, but same-store sales rose a better-than-expected eight percent during the quarter, excluding fuel sales.
Joy Global – The mining equipment maker missed estimates by 11 cents with adjusted quarterly profit of 25 cents per share, amid commodity price weakness. Revenue was below forecasts, as is the company's fiscal 2015 forecast.
Dunkin' Brands – Goldman upgraded Dunkin' to "buy" from "neutral," pointing to increasing sales, better results from its "Perks" loyalty program, and an expected earnings contribution from its new distribution deal for its coffee.
L Brands – The parent company of Victoria's Secret and Bath & Body Works reported a same-store sales increase of six percent for February, above estimates of a 4.9 percent rise.
McDonald's – Piper Jaffray downgraded the stock to "neutral" from "overweight," saying that the stock is appropriately valued after a recent 12 percent increase, and that initiatives to increase sales may work more slowly many expect.
Buckle – A surprise decline in February sales for the teen retailer. Same store sales fell 2.7 percent, well below consensus estimates of a 0.1 percent increase.
General Dynamics – The defense contractor increased its quarterly dividend to 69 cents per share from 62 cents, a rise of 11 percent.
Citigroup – Citi sold its nearly 10 percent stake in Turkey's Akbank for $1.2 billion, as it continues its move to dispose of overseas assets.
Apple – Apple is said to be delaying the start of production for a planned larger iPad, according to reports. Production is now more likely to begin in September, because of supply issues with larger display panels.
Simon Property Group – Simon is mulling a bid for rival mall owner Macerich, according to the Wall Street Journal. Simon hasn't made a formal offer as yet, although it did reveal a 3.6 percent stake in Macerich last year.
Caesars Entertainment – Caesars won court approval to use some of its cash on hand for at least five weeks. Some creditors of the bankrupt casino operator had registered objections to letting Caesars go through with a plan to spend $334 million through April 3.